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351 Mechanical support of total cavopulmonary connection with an axial flow
pump
R. Kirk Riemer, PhD, Gabriel Amir, MD, Steven H. Reichenbach, PhD, and
Olaf Reinhartz, MD, Stanford and Pleasanton, Calif
The hemodynamic response to TCPC was studied in a sheep model. TCPC resulted in
significantly reduced aortic flow and arterial pressure. When an axial flow pump was used to
support TCPC, these unfavorable hemodynamics were restored to normal.
355 Local delivery of osteopontin attenuates vascular remodeling by altering
matrix metalloproteinase-2 in a rabbit model of aortic injury
Ralf G. Seipelt, MD, Carl L. Backer, MD, Constantine Mavroudis, MD,
Veronica Stellmach, PhD, Mona Cornwell, HT, Ingrid M. Seipelt, MD,
Friedrich A. Schoendube, MD, and Susan E. Crawford, MD, Chicago, Ill, and Göttingen,
Germany
The role of locally applied osteopontin, a bone-associated protein, on vascular remodeling was
studied after arterial injury. Osteopontin significantly diminished vascular stenosis and
calcification probably by altering MMP-2 activity and SMC proliferation. Brief application of
osteopontin may be an effective treatment to overcome pathologic vascular remodeling
postinjury.
363 A novel protocol of retrograde cerebral perfusion with intermittent pressure
augmentation for brain protection
Kazuo Kitahori, MD, Shinichi Takamoto, MD, PhD, Hiroo Takayama, MD,
Yoshihiro Suematsu, MD, PhD, Minoru Ono, MD, PhD, Noboru Motomura, MD, PhD,
Teturo Morota, MD, PhD, and Kengo Takeuchi, MD, PhD, Tokyo, Japan
RCP with intermittent pressure augmentation effectively opened up retinal vessels and allowed
adequate blood supply to the brain, resulting in more effective brain protection than that
obtained with conventional RCP in a canine model. We believe that this novel protocol would
be very useful for aortic operations.
371 Pretreatment with an adenosine A1 receptor agonist and lidocaine: A
possible alternative to myocardial ischemic preconditioning
Sarah J. Canyon, PhD, and Geoffrey P. Dobson, PhD, Queensland, Australia
A therapeutic goal for more than 2 decades has been to develop a pharmacologic mimetic
comparable with ischemic preconditioning. We conclude that activating adenosine A1 receptor
subtype with CCPA and concomitantly modulating Na fast channels with lidocaine might
offer a new therapeutic window to minimize myocardial damage during surgical ischemia and
reperfusion.
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